527 related articles for article (PubMed ID: 29128526)
21. Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase.
Errington WJ; Khan MQ; Bueler SA; Rubinstein JL; Chakrabartty A; Privé GG
Structure; 2012 Jul; 20(7):1141-53. PubMed ID: 22632832
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex.
Kim B; Nam HJ; Pyo KE; Jang MJ; Kim IS; Kim D; Boo K; Lee SH; Yoon JB; Baek SH; Kim JH
Biochem Biophys Res Commun; 2011 Dec; 415(4):720-6. PubMed ID: 22085717
[TBL] [Abstract][Full Text] [Related]
23. The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.
Cheng J; Guo J; North BJ; Tao K; Zhou P; Wei W
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):138-159. PubMed ID: 30602127
[TBL] [Abstract][Full Text] [Related]
24. Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1.
Li C; Ao J; Fu J; Lee DF; Xu J; Lonard D; O'Malley BW
Oncogene; 2011 Oct; 30(42):4350-64. PubMed ID: 21577200
[TBL] [Abstract][Full Text] [Related]
25. A conserved N-terminal motif of CUL3 contributes to assembly and E3 ligase activity of CRL3
Wang W; Liang L; Dai Z; Zuo P; Yu S; Lu Y; Ding D; Chen H; Shan H; Jin Y; Mao Y; Yin Y
Nat Commun; 2024 May; 15(1):3789. PubMed ID: 38710693
[TBL] [Abstract][Full Text] [Related]
26. Defective protein degradation in genetic disorders.
Castel P
Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166366. PubMed ID: 35158019
[TBL] [Abstract][Full Text] [Related]
27. Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover.
Zhang P; Gao K; Jin X; Ma J; Peng J; Wumaier R; Tang Y; Zhang Y; An J; Yan Q; Dong Y; Huang H; Yu L; Wang C
Cell Death Dis; 2015 Mar; 6(3):e1687. PubMed ID: 25766326
[TBL] [Abstract][Full Text] [Related]
28. Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments.
Bouchard JJ; Otero JH; Scott DC; Szulc E; Martin EW; Sabri N; Granata D; Marzahn MR; Lindorff-Larsen K; Salvatella X; Schulman BA; Mittag T
Mol Cell; 2018 Oct; 72(1):19-36.e8. PubMed ID: 30244836
[TBL] [Abstract][Full Text] [Related]
29. BTB/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases.
Geyer R; Wee S; Anderson S; Yates J; Wolf DA
Mol Cell; 2003 Sep; 12(3):783-90. PubMed ID: 14527422
[TBL] [Abstract][Full Text] [Related]
30. Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles.
Marzahn MR; Marada S; Lee J; Nourse A; Kenrick S; Zhao H; Ben-Nissan G; Kolaitis RM; Peters JL; Pounds S; Errington WJ; Privé GG; Taylor JP; Sharon M; Schuck P; Ogden SK; Mittag T
EMBO J; 2016 Jun; 35(12):1254-75. PubMed ID: 27220849
[TBL] [Abstract][Full Text] [Related]
31. New strategies to inhibit KEAP1 and the Cul3-based E3 ubiquitin ligases.
Canning P; Bullock AN
Biochem Soc Trans; 2014 Feb; 42(1):103-7. PubMed ID: 24450635
[TBL] [Abstract][Full Text] [Related]
32. CAND1 exchange factor promotes Keap1 integration into cullin 3-RING ubiquitin ligase during adipogenesis.
Dubiel D; Ordemann J; Pratschke J; Dubiel W; Naumann M
Int J Biochem Cell Biol; 2015 Sep; 66():95-100. PubMed ID: 26219975
[TBL] [Abstract][Full Text] [Related]
33. SPOP in Cancer: Phenomena, Mechanisms and Its Role in Therapeutic Implications.
Yang X; Zhu Q
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360288
[TBL] [Abstract][Full Text] [Related]
34. Cullin 4-DCAF Proteins in Tumorigenesis.
Zhou Z; Song X; Wavelet CM; Wan Y
Adv Exp Med Biol; 2020; 1217():241-259. PubMed ID: 31898232
[TBL] [Abstract][Full Text] [Related]
35. HECT-Type E3 Ubiquitin Ligases in Cancer.
Bernassola F; Chillemi G; Melino G
Trends Biochem Sci; 2019 Dec; 44(12):1057-1075. PubMed ID: 31610939
[TBL] [Abstract][Full Text] [Related]
36. The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase.
Pintard L; Willis JH; Willems A; Johnson JL; Srayko M; Kurz T; Glaser S; Mains PE; Tyers M; Bowerman B; Peter M
Nature; 2003 Sep; 425(6955):311-6. PubMed ID: 13679921
[TBL] [Abstract][Full Text] [Related]
37. Cullin3/KCTD5 induces monoubiquitination of ΔNp63α and impairs its activity.
He H; Peng Y; Fan S; Chen Y; Zheng X; Li C
FEBS Lett; 2018 Jul; 592(13):2334-2340. PubMed ID: 29782646
[TBL] [Abstract][Full Text] [Related]
38. Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants.
Zhang P; Gao K; Tang Y; Jin X; An J; Yu H; Wang H; Zhang Y; Wang D; Huang H; Yu L; Wang C
Hum Mutat; 2014 Sep; 35(9):1142-51. PubMed ID: 24990631
[TBL] [Abstract][Full Text] [Related]
39. Dynamic molecular architecture and substrate recruitment of cullin3-RING E3 ligase CRL3
Hu Y; Zhang Z; Mao Q; Zhang X; Hao A; Xun Y; Wang Y; Han L; Zhan W; Liu Q; Yin Y; Peng C; Moresco EMY; Chen Z; Beutler B; Sun L
Nat Struct Mol Biol; 2024 Feb; 31(2):336-350. PubMed ID: 38332366
[TBL] [Abstract][Full Text] [Related]
40. ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression.
Fan Y; Hou T; Dan W; Zhu Y; Liu B; Wei Y; Wang Z; Gao Y; Zeng J; Li L
Cell Death Differ; 2022 Aug; 29(8):1611-1624. PubMed ID: 35194188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
